
Profile
General Information
For the treatment of recurrent mucocutaneous herpes simplex infections in HIV-infected patients.
Approval Date: 1999-01-01
Company Name: SmithKline Beecham
For the treatment of recurrent mucocutaneous herpes simplex infections in HIV-infected patients.